Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 3.5.2024Zentiva, k.s. (ZNT-1)81835Valzap HCT 160 mg/25 mg (tbl flm 28x160 mg/25 mg (blis.PVC/PE/PVDC/Al))6.5.2024O
 3.5.2024Zentiva, k.s. (ZNT-1)01069Fungicidin Léčiva (ung 1x10 g (tuba Al))6.5.2024O
 3.5.2024Zentiva, k.s. (ZNT-1)05476ZODAC (tbl flm 7x10 mg (blis.PVC/PVDC/Al))6.5.2024O
 3.5.2024B.Braun Melsungen AG (BME)13744Braunol (sol der 1x5 l (kanister PE))3.5.2024R
 2.5.2024Upjohn EESV (UPO-NL)62569Norvasc 5 mg tablety (tbl 30x5 mg (blis.PVC/PVDC/Al))6.5.2024R
 2.5.2024Eli Lilly Nederland B.V. (LIL-NL-2)89134Humalog 100 U/ml, injekčný roztok v injekčnej liekovke (sol inj 1x10 ml (liek.inj.skl.))3.5.2024R
 2.5.2024Mylan Pharmaceuticals Limited (MLB-IE-1)5235AMemantin Mylan 20 mg filmom obalené tablety (tbl flm 28x20 mg (blis.PVC/PVDC/Al))13.5.2024R
 2.5.2024B.Braun Melsungen AG (BME)5716ARingerfundin (sol inf 10x500 ml (fľ.PE))2.5.2024O
 2.5.2024TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)9359BEzetimib Teva 10 mg (tbl 98x10 mg (blis.PVC/Aclar/PVC/Al))14.5.2024R
 2.5.2024Teva B.V. (TEV-NL-4)8602BAtomoxetine Actavis 40 mg (cps dur 28x40 mg (blis.PVC/PVDC/PVC/Al))20.6.2024R
 2.5.2024ratiopharm GmbH (RAT)35324Perindopril-ratiopharm 4 mg (tbl 90x4 mg (blis.PVC/PE/PVDC/Al))20.5.2024R
 2.5.2024B.Braun Melsungen AG (BME)4143CIbuprofen B. Braun 400 mg (sol inf 10x400 mg/100 ml (fľ.LDPE))2.5.2024R
 2.5.2024Opella Healthcare Slovakia s.r.o. (OPL)86051PARALEN 500 (tbl 12x500 mg (blis.Al/PVC))29.4.2024Z
 2.5.2024Hikma Farmaceutica (Portugal) S.A. (HKP-P)84495TRIFED EXPECTORANT (sir 1x100 ml (fľ.PVC hnedá))2.5.2024R
 2.5.2024Hikma Farmaceutica (Portugal) S.A. (HKP-P)43116MEGAMOX DUO (plu por 1x70 ml (fľ.PE))2.5.2024R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)